Global Pharma Sales Growth Slows To Record Low Thanks To Recession - IMS
This article was originally published in The Pink Sheet Daily
Executive Summary
A revised forecast by IMS Health sees just 2.5 percent to 3.5 percent growth this year, with currency fluctuations getting much of the blame.